rs1145

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000484.4(APP):​c.2211+4020G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0794 in 152,024 control chromosomes in the GnomAD database, including 639 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.079 ( 639 hom., cov: 32)

Consequence

APP
NM_000484.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.195

Publications

5 publications found
Variant links:
Genes affected
APP (HGNC:620): (amyloid beta precursor protein) This gene encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Aug 2014]
APP Gene-Disease associations (from GenCC):
  • Alzheimer disease type 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • cerebral amyloid angiopathy, APP-related
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • ABeta amyloidosis, Arctic type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, dutch type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, Iowa type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABeta amyloidosis, Italian type
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABetaA21G amyloidosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ABetaL34V amyloidosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset autosomal dominant Alzheimer disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APPNM_000484.4 linkc.2211+4020G>A intron_variant Intron 17 of 17 ENST00000346798.8 NP_000475.1 P05067-1A0A140VJC8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APPENST00000346798.8 linkc.2211+4020G>A intron_variant Intron 17 of 17 1 NM_000484.4 ENSP00000284981.4 P05067-1

Frequencies

GnomAD3 genomes
AF:
0.0794
AC:
12063
AN:
151906
Hom.:
639
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0201
Gnomad AMI
AF:
0.241
Gnomad AMR
AF:
0.0658
Gnomad ASJ
AF:
0.0629
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0604
Gnomad FIN
AF:
0.0980
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.122
Gnomad OTH
AF:
0.0789
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0794
AC:
12064
AN:
152024
Hom.:
639
Cov.:
32
AF XY:
0.0769
AC XY:
5712
AN XY:
74284
show subpopulations
African (AFR)
AF:
0.0200
AC:
830
AN:
41478
American (AMR)
AF:
0.0657
AC:
1003
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.0629
AC:
218
AN:
3468
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5172
South Asian (SAS)
AF:
0.0611
AC:
294
AN:
4812
European-Finnish (FIN)
AF:
0.0980
AC:
1032
AN:
10534
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.122
AC:
8265
AN:
67972
Other (OTH)
AF:
0.0781
AC:
165
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
577
1155
1732
2310
2887
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0379
Hom.:
43
Bravo
AF:
0.0740
Asia WGS
AF:
0.0320
AC:
112
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
3.9
DANN
Benign
0.74
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1145; hg19: chr21-27260014; API